Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
NCT: NCT05904132 · RECRUITING
Brief Summary
The project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation (tACS) to study patients with symptoms of mild cognitive impairment which is likely due to Alzheimer's disease or another form of dementia (AD-MCI). Patients will undergo an EEG and complete some questionnaires and computer tasks during each study visit. The project has the following aims and hypotheses: 1.) To determine the impact of closed-loop 40 Hz tACS on the entrainment of natural gamma rhythms in patients with AD-MCI, 2.) To determine the impact of closed-loop 40 Hz tACS on cognitive performance in patients with AD-MCI, and 3.) To assess the relationship between baseline neurodegenerative burden and impact of tACS. \[exploratory\]
Frequently Asked Questions
What is Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease?
Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease is a clinical trial registered under NCT05904132. Current status: RECRUITING.
What is the status of NCT05904132?
The current status of NCT05904132 (Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease) is: RECRUITING.
When did Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease start?
Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease started on 2025-01-31.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.